On Friday, three recent studies suggested more evidence that Coronavirus vaccines stand up to the highly contagious Omicron variant, at least among individuals who received booster vaccine doses. In addition, health officials said they are the first large U.S. studies to look at vaccine protection against the deadly variant. The documents reiterate previous research – including studies in the United Kingdom, Germany, and South Africa – signifying available COVID-19 vaccines are less effective against the highly infectious Omicron variant than earlier variants of the COVID-19, but also that booster doses significantly improve protection.
Friday released three studies from the U.S. CDC offered more evidence that Coronavirus vaccines are standing up to the highly contagious Omicron variant, especially among individuals who received vaccine booster doses. pic.twitter.com/nThZxeYM6z
— Live News Now (@LiveNewsNow6) January 22, 2022
The preliminary study looked at ten states’ emergency room, hospitalizations, and urgent care center visits from August to January. It found the effectiveness of the vaccine was best after three shots of the Moderna or Pfizer vaccines in preventing Coronavirus-related urgent care visits and emergency department. However, protection against the virus plummeted from ninety-four percent during the Delta variant wave to eighty-two percent during the Omicron wave. Furthermore, protection from only two shots was lower, especially six months after the second shot.
The Second and Third Study
The second study on Coronavirus focused on case and death rates in twenty-five states from the starting of April through Christmas. Again, individuals who received booster shots had the highest protection against COVID-19 infection, both during the time was dominant and when the Omicron variant was taking over. In addition, the Centers for Disease Control and Prevention (CDC) published both articles online.
On the other hand, the Journal of the American Medical Association published the 3rd study, also led by CDC researchers. It looked at individuals who tested positive for Coronavirus from 10th December to 1st January at over forty-six hundred testing sites all over the United States. Three doses of the Moderna and Pfizer vaccines were around sixty-seven percent effective against Omicron-related symptomatic illness compared with unvaccinated individuals.
Omicron Spike Tests Coronavirus Prevention Efforts at Immigration Facilities
The instantly spreading Omicron variant is testing the ability of the United States authorities to keep a large number of migrants healthy at overcrowded detention centers, where Coronavirus prevention moves were virtually absent at the starting of the outbreak but since improved.
According to ICE statistics, over twenty-five hundred individuals tested positive for Coronavirus Friday in the Immigration and Customs Enforcement (ICE) one hundred and ninety-eight immigration detention centers countrywide. It states an increase of over seven hundred and ninety-two percent from two hundred and eighty-five cases reported on 3rd January. Moreover, the hike in cases amid a countrywide surge in new cases because of the highly transmissible Omicron variant.
Read Also: US Supreme Court Blocks Federal COVID Vaccine Mandate for Businesses